U.S. markets close in 4 hours 13 minutes
  • S&P 500

    4,146.36
    +4.77 (+0.12%)
     
  • Dow 30

    33,901.67
    +224.40 (+0.67%)
     
  • Nasdaq

    13,966.19
    -29.91 (-0.21%)
     
  • Russell 2000

    2,266.36
    +37.44 (+1.68%)
     
  • Crude Oil

    62.85
    +2.67 (+4.44%)
     
  • Gold

    1,735.80
    -11.80 (-0.68%)
     
  • Silver

    25.42
    -0.00 (-0.00%)
     
  • EUR/USD

    1.1977
    +0.0023 (+0.19%)
     
  • 10-Yr Bond

    1.6410
    +0.0180 (+1.11%)
     
  • GBP/USD

    1.3798
    +0.0046 (+0.33%)
     
  • USD/JPY

    108.9560
    -0.0920 (-0.08%)
     
  • BTC-USD

    62,980.89
    -15.54 (-0.02%)
     
  • CMC Crypto 200

    1,357.07
    -18.71 (-1.36%)
     
  • FTSE 100

    6,938.95
    +48.46 (+0.70%)
     
  • Nikkei 225

    29,620.99
    +82.29 (+0.28%)
     

Nuance Acquires Clinical AI Competences Startup Saykara

  • Oops!
    Something went wrong.
    Please try again later.
Anusuya Lahiri
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Nuance Communications, Inc. (NASDAQ: NUANacquired a clinical artificial intelligence (AI) startup Saykara, Inc., to bolster its AI and ambient clinical intelligence (ACI) solutions towards lower clinician burnout, improved patient experiences, and better overall health system financial integrity.

  • Harjinder Sandhu, Ph.D., founded Saykara in Seattle in 2015 and previously served in Nuance’s R&D division. The financial terms of the transaction remain undisclosed.

  • Sandhu and Saykara’s team of engineers, machine learning specialists, and qualified technology executives will join Nuance’s R&D team.

  • Nuance’s cash flow from operations increased from $44.7 million to $54.6 million year-on-year in the first quarter of FY21. The closing cash balance stood at $374 million.

  • Price action: NUAN shares are down 2.99% at $49 in the pre-market session on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.